Loading…
Loading…
EQUITY / NASDAQ · XNCM
Jin Medical International Ltd. Class A Ordinary Shares
No accepted understanding yet. Follow this company to establish research where evidence supports it.
Open research workspace →10/01/2024 – 09/30/2025 · USD · Units
Reported figures establish facts for this period; they do not by themselves establish a profitability trend.
Open report ↗1.98 USD
Observed: 10/05/2026 · tickerlayer · Historical end-of-day close
Powered by TickerLayer
10/05/2026 · 1.98 USD · Volume 6,001
679 actual observations · Latest bar: 2026-10-05 · Market data is indicative; provider terms apply.
3 available financial reports
Research reports →SEC FINANCIAL REPORTS
10/01/2024 – 09/30/2025 · Units
| Metric | 2025 / Year end | 2024 / Year end | Change |
|---|---|---|---|
| Revenue | 20,687,274 USD | 23,502,010 USD | -11.98% |
| Operating profit | 608,182 USD | 3,638,748 USD | -83.29% |
| Net income | 1,191,297 USD | 3,675,927 USD | -67.59% |
| Operating cash flow | 2,903,584 USD | -1,207,305 USD | — |
| Total liabilities | 23,795,891 USD | 17,248,309 USD | +37.96% |
Changes are calculated only for matching period length, consolidation, currency, and scale. Percentages are not shown for zero or negative baselines.
Each column uses its report's scale. Check column headers before comparing different consolidation scopes and scales.
| Financial metric | 2025 / Year end10/01/2024 – 09/30/2025ConsolidatedUnits · USD | 2024 / Year end10/01/2023 – 09/30/2024ConsolidatedUnits · USD | 2023 / Year end10/01/2022 – 09/30/2023ConsolidatedUnits · USD |
|---|---|---|---|
| Capital expendituresCash flow statement | 6,629,800 USD | 144,949 USD | 113,937 USD |
| Financing cash flowCash flow statement | 7,353,245 USD | 11,654,357 USD | 6,910,619 USD |
| Gross profitIncome statement | 6,044,533 USD | 9,502,769 USD | 6,784,834 USD |
| Investing cash flowCash flow statement | -10,791,736 USD | -9,514,007 USD | -7,730,248 USD |
| Net incomeIncome statement | 1,191,297 USD | 3,675,927 USD | 2,878,230 USD |
| Operating cash flowCash flow statement | 2,903,584 USD | -1,207,305 USD | 3,106,403 USD |
| Operating profitIncome statement | 608,182 USD | 3,638,748 USD | 2,867,262 USD |
| RevenueIncome statement | 20,687,274 USD | 23,502,010 USD | 19,821,457 USD |
| Total assetsBalance sheet | 53,368,358 USD | 45,800,769 USD | — |
| Total equityBalance sheet | 29,638,722 USD | 28,815,184 USD | 23,979,105 USD |
| Total liabilitiesBalance sheet | 23,795,891 USD | 17,248,309 USD | — |
| Report source | Open report ↗ Published: 02/10/2026 | Open report ↗ Published: 02/10/2026 | Open report ↗ Published: 02/10/2026 |
The latest available source version is shown for each period. Previous versions and correction relationships are not shown in this view.